Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epileptic Hippocampus in Alzheimer's Disease

NCT05899764 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05899764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05899764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epileptic Hippocampus in Alzheimer's Disease
Lead sponsor
University of California, Los Angeles
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
June 1, 2029
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment